Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Blood

Volumn 128, Issue 16, 2016, Pages 2096-2097

  Greenberg, Peter L ^a   Tuechler, Heinz ^b   Schanz, Julie ^c   Sanz, Guillermo ^d   Garcia Manero, Guillermo ^e   Solé, Francesc ^f   Bennett, John M ^g   Bowen, David ^h   Fenaux, Pierre ⁱ   Dreyfus, Francois ^j   Kantarjian, Hagop ^e   Kuendgen, Andrea ^k   Levis, Alessandro ^l   Malcovati, Luca ^m   Cazzola, Mario ^m   Cermak, Jaroslav ⁿ   Fonatsch, Christa ^o   Le Beau, Michelle M ^p   Slovak, Marilyn L ^q   Krieger, Otto ^r   Luebbert, Michael ^s   Maciejewski, Jaroslaw ^t   Magalhaes, Silvia M M ^u   Miyazaki, Yasushi ^v   Pfeilstöcker, Michael ^b   Sekeres, Mikkael ^t   Sperr, Wolfgang R ^o   Stauder, Reinhard ^w   Tauro, Sudhir ^x   Valent, Peter ^o   Vallespi, Teresa ^y   Van De Loosdrecht, Arjan A ^z   Germing, Ulrich ^k   Haase, Detlef ^c   more..

^a STANFORD CANCER INSTITUTE   (United States)

^b HANUSCH HOSPITAL   (Austria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF TEXAS   (United States)

^f HOSPITAL DEL MAR   (Spain)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ AVICENNE HOSPITAL   (France)

^j Institut Cochin   (France)

^k UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^l UOS Antonio e Biagio e C Arrigo Hospital   (Italy)

^m UNIVERSITY OF PAVIA   (Italy)

ⁿ INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^o MEDICAL UNIVERSITY OF VIENNA   (Austria)

^p UNIVERSITY OF CHICAGO   (United States)

^q QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^r ELISABETHINEN HOSPITAL   (Austria)

^s UNIVERSITY OF FREIBURG   (Germany)

^t LERNER RESEARCH INSTITUTE   (United States)

^u FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^v NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^w UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^x UNIVERSITY OF DUNDEE   (United Kingdom)

^y HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^z VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CELL COUNT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOPENIA; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; ANEMIA; LEUKOPENIA; THROMBOCYTOPENIA;

ANEMIA; HUMANS; LEUKOPENIA; MYELODYSPLASTIC SYNDROMES; THROMBOCYTOPENIA;

EID: 84992317461     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-07-728766     Document Type: Letter

References (18)

1. Arber DA, Orazi A, Hasserjian R., et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-2405.
2. Brunning RD, Orazi A, Germing U., et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow S, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC Press; 2008:88.
3. Wimazal F, Fonatsch C, Thalhammer R., et al. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface. Leuk Res. 2007; 31(11):1461-1468.
4. Kwok B, Hall JM, Witte J.S., et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 2015; 126(21):2355-2361.
5. Valent P, Bain BJ, Bennett J.M., et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res. 2012; 36(1):1-5.
6. Valent P, Jäger E, Mitterbauer-Hohendanner G, et al. Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis. Am J Cancer Res. 2011; 1(4):531-541.
7. Steensma DP, Bejar R, Jaiswal S., et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015; 126(1): 9-16.
8. McKerrell T, Park N, Moreno T., et al; Understanding Society Scientific Group. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Reports. 2015; 10(8):1239-1245.
9. Cargo CA, Rowbotham N, Evans P.A., et al. Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. Blood. 2015; 126(21):2362-2365.
10. Greenberg PL, Stone R, Bejar R., et al., eds. NCCN Practice Guidelines for Myelodysplastic Syndromes, version 1. 2017. (www.nccn.org/professionals/physician-gls/PDF/mds.pdf).
11. Greenberg P, Cox C, LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997; 89(6): 2079-2088.
12. Greenberg PL, Tuechler H, Schanz J., et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012; 120(12): 2454-2465.
13. Germing U, Strupp C, Kuendgen A., et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica. 2006; 91(12):1596-1604.
14. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006; 107(5):1747-1750.
15. Beutler E. Hemoglobin levels, altitude, and smoking. Blood. 2006; 108(6): 2131-2132.
16. Segal JB, Moliterno AR Platelet counts differ by sex, ethnicity, and age in the United States. Ann Epidemiol. 2006; 16(2):123-130.
17. Biino G, Santimone I, Minelli C., et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One. 2013; 8(1):e54289.
18. Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996; 49(8):664-666. DOI 10.1182/blood-2016-07-728766